Triple

T10214690
Position Surface form Disambiguated ID Type / Status
Subject Avsola E242411 entity
Predicate isBiosimilarTo P37220 FINISHED
Object infliximab
Infliximab is a chimeric monoclonal antibody that targets tumor necrosis factor alpha (TNF-α) and is widely used to treat autoimmune inflammatory diseases such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
 E49851 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: infliximab | Statement: [Avsola, isBiosimilarTo, infliximab]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: infliximab
Context triple: [Avsola, isBiosimilarTo, infliximab]
  • A. infliximab-qbtx
    Infliximab-qbtx is a monoclonal antibody biosimilar to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
  • B. infliximab-axxq
    Infliximab-axxq is a monoclonal antibody biosimilar to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
  • C. Remicade
    Remicade is a widely used monoclonal antibody biologic (infliximab) prescribed to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
  • D. Humira
    Humira is a widely used biologic medication (adalimumab) that treats various autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn’s disease by inhibiting tumor necrosis factor (TNF).
  • E. Stelara
    Stelara is a prescription biologic medication (ustekinumab) used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and Crohn’s disease by targeting specific immune system pathways.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: infliximab
Triple: [Avsola, isBiosimilarTo, infliximab]
Generated description
Infliximab is a chimeric monoclonal antibody that targets tumor necrosis factor alpha (TNF-α) and is widely used to treat autoimmune inflammatory diseases such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: infliximab
Target entity description: Infliximab is a chimeric monoclonal antibody that targets tumor necrosis factor alpha (TNF-α) and is widely used to treat autoimmune inflammatory diseases such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
  • A. infliximab-qbtx
    Infliximab-qbtx is a monoclonal antibody biosimilar to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
  • B. infliximab-axxq
    Infliximab-axxq is a monoclonal antibody biosimilar to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
  • C. Remicade chosen
    Remicade is a widely used monoclonal antibody biologic (infliximab) prescribed to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
  • D. Humira
    Humira is a widely used biologic medication (adalimumab) that treats various autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn’s disease by inhibiting tumor necrosis factor (TNF).
  • E. Stelara
    Stelara is a prescription biologic medication (ustekinumab) used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and Crohn’s disease by targeting specific immune system pathways.
  • F. None of above.

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d381ae26c48190985abd0e25ee5d04 completed April 6, 2026, 9:49 a.m.
NER Named-entity recognition batch_69d4d1f860048190bb20f7d3bf87f347 completed April 7, 2026, 9:44 a.m.
NED1 Entity disambiguation (via context triple) batch_69d71c77f65c8190862fde1c2fae045b completed April 9, 2026, 3:26 a.m.
NEDg Description generation batch_69d71f76e3cc8190b21a5fe8825caa2b completed April 9, 2026, 3:39 a.m.
NED2 Entity disambiguation (via description) batch_69d7319938ec8190a4a1a5f09832e3e3 completed April 9, 2026, 4:56 a.m.
Created at: April 6, 2026, 11:04 a.m.